A study on PC3 prostate cancer cells demonstrated that following GPRC5A knockout with CRISPR/Cas9, cell proliferation was significantly decreased via induction of cell cycle arrest at the G2/M phase in GPRC5A KO PC3 cells. This evidence concerns the gene GPRC5A and prostate carcinoma.